Benjamin obtained his PhD in 2011 at the Free University of Brussels. During his postdoctoral positions, he joined different research centers in Canada, France and Belgium to develop competences in the oncology and senescence fields. Recently, he was a member of the research and development department of a biopharmaceutical company specialized in immunotherapy.